EGFR and adenocarcinoma: Kaplan–Meier curves indicated significantly longer survival in patients with favourable PS (P<0.0001), in patients with adenocarcinoma histology (P<0.0001), in never-smokers (P<0.0001), and in patients with EGFR mutations (P<0.0001) (Table 1, Figure 1).